References
- ShaoPLHuangLMHsuehPRRecent advances and challenges in the treatment of invasive fungal infectionsInt J Antimicrob Agents200730648749517961990
- PfallerMADiekemaDJEpidemiology of invasive candidiasis: a persistent public health problemClin Microbiol Rev200720113316317223626
- DabasPSAn approach to etiology, diagnosis and management of different types of candidiasisJ Yeast Fungal Res2013466374
- Calzavara-PintonPGVenturiniMSalaRA comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skinJ Photochem Photobiol B Biol200578116
- VermaSBhardwajAVijMBajpaiPGoutamNKumarLOleic acid vesicles: a new approach for topical delivery of antifungal agentArtif Cells Nanomed Biotechnol20144229510123656670
- ZhangZTsaiP-CRamezanliTMichniak-KohnBBPolymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseasesWiley Interdiscip Rev Nanomedicine Nanobiotechnology20135320521823386536
- GuptaMGoyalAKPaliwalSRDevelopment and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasisJ Liposome Res201020434135020163329
- AggarwalNGoindiSPreparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-dermatophytosisInt J Pharm20124371–227728722939964
- KyleAADahlMVTopical therapy for fungal infectionsAm J Clin Dermatol20045644345115663341
- ZhangAYCampWLElewskiBEAdvances in topical and systemic antifungalsDermatol Clin200725216518317430754
- LewisRECurrent concepts in antifungal pharmacologyMayo Clin Proc201186880581721803962
- MaertensJAHistory of the development of azole derivativesClin Microbiol Infect2004101110
- FromtlingRAOverview of medically important antifungal azole derivativesClin Microbiol Rev1988121872173069196
- SoodGNyirjesyPWeitzMVChatwaniATerconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysisInfect Dis Obstet Gynecol200085–624024311220485
- OddsFCWebsterCEAbottABAntifungal relative inhibition factors: BAY 1-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agentsJ Antimicrob Chemother1984141051146094418
- CooperCRMcGinnisMRIn vitro susceptibility of clinical yeast isolates to fluconazole and terconazoleAm J Obstet Gynecol19961756162616318987951
- RingdahlENTreatment of recurrent vulvovaginal candidiasisAm Fam Physician200061113306331210865926
- CarrPLFelsensteinDFriedmanRHEvaluation and management of vaginitisJ Gen Intern Med19981353353469613891
- GüngörSErdalMSAksuBNew formulation strategies in topical antifungal therapyJ Cosmet Dermatological Sci Appl2013315665
- ZakirFVaidyaBGoyalAKMalikBVyasSPDevelopment and characterization of oleic acid vesicles for the topical delivery of fluconazoleDrug Deliv201017423824820235758
- BensonHATransdermal drug delivery: penetration enhancement techniquesCurr Drug Deliv200521233316305405
- PrausnitzMRLangerRTransdermal drug deliveryNat Biotechnol200826111261126818997767
- MorrowDIJMccarronPAWoolfsonADDonnellyRFInnovative strategies for enhancing topical and transdermal drug deliveryOpen Drug Deliv J200713659
- NairAJacobSAl-DhubiabBAttimaradMHarshaSBasic considerations in the dermatokinetics of topical formulationsBrazilian J Pharm Sci2013493423434
- ElnaggarYSREtmanSAbdelmonsifDAAbdallahOYNovel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studiesInt J Nanomedicine2015105459547326346130
- El-refaieWMElnaggarYSREl-MassikMAAbdallahOYNovel Self-assembled, gel-core hyaluosomes for non-invasive management of osteoarthritis: in-vitro optimization, ex-vivo and in-vivo permeationPharm Res2015322901291125777613
- ElsheikhMAElnaggarYSRGoharEYAbdallahOYNanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInt J Nanomedicine201273787380222888234
- FreagMSElnaggarYSRAbdallahOYLyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeationInt J Nanomedicine201382385239723861584
- ElnaggarYSREl-MassikMAAbdallahOYFabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticlesInt J Nanomedicine201163195320522238508
- ZhaiYZhaiGAdvances in lipid-based colloid systems as drug carrier for topic deliveryJ Control Release2014193909924939745
- DasSChaudhuryARecent advances in lipid nanoparticle formulations with solid matrix for oral drug deliveryAAPS PharmSciTech2011121627621174180
- AttamaAAMomohMABuildersPFLipid nanoparticulate drug delivery systems: a revolution in dosage form design and developmentDemir SezerARecent Adv Novel Drug Carrier Syst2012107140
- OmrayLKLiquid crystals as novel vesicular delivery system: a reviewCurr Trends Technol Sci201325347353
- NesseemDIFormulation and evaluation of itraconazole via liquid crystal for topical delivery systemJ Pharm Biomed Anal200126338739911489384
- GosencaMBešter-RogačMGašperlinMLecithin based lamellar liquid crystals as a physiologically acceptable dermal delivery system for ascorbyl palmitateEur J Pharm Sci201350111412223643736
- LopesLBSperettaFFFBentleyMVLBEnhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systemsEur J Pharm Sci200732320921517900879
- WavikarPVaviaPNanolipidgel for enhanced skin deposition and improved antifungal activityAAPS PharmSciTech201314122223323263751
- KumarJMuralidharanSParasuramanSEvaluation of antifungal activity of sustained release microsponge enriched fluconazole gel for penile candidiasis in male ratsInt J PharmTech Res20146618881897
- ChorilliMPrestesPSRigonRBStructural characterization and in vivo evaluation of retinyl palmitate in non-ionic lamellar liquid crystalline systemColloids Surf B Biointerfaces201185218218821411295
- OzcanIAbaciOUztanAHEnhanced topical delivery of terbinafine hydrochloride with chitosan hydrogelsAAPS PharmSciTech20091031024103119662536
- KumarLVermaSJamwalSVaidyaSVaidyaBPolymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterizationPharm Dev Technol201419331832523560821
- ElmoslemanyRMAbdallahOYEl-KhordaguiLKKhalafallahNMPropylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomesAAPS PharmSciTech201213272373122566173
- VaghasiyaHKumarASawantKDevelopment of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochlorideEur J Pharm Sci201349231132223557842
- IACUC Faculty and StaffGuideline on anesthesia and analgesia in laboratory animalsUniversity of South Florida120 Available from: https://www.scribd.com/document/250122043/Guidelines-on-Anesthesia-and-Analgesia-in-Laboratory-AnimalsAccessed September 1, 2016
- ButaniDYewaleCMisraAAmphotericin B topical microemulsion: formulation, characterization and evaluationColloids Surf B Biointerfaces201411635135824521698
- ShishuAggarwalNPreparation of hydrogels of griseofulvin for dermal applicationInt J Pharm20063261–2202416920284
- SahooSPaniNRSahooSKMicroemulsion based topical hydrogel of sertaconazole: formulation, characterization and evaluationColloids Surf B Biointerfaces201412019319924953450
- El-RefaieWMElnaggarYSREl-MassikMAAbdallahOYNovel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: development, in-vitro appraisal and in-vivo studiesInt J Pharm20154861–2889825818063
- SongSHLeeKMKangJBLeeSGKangMJChoiYWImproved skin delivery of voriconazole with a nanostructured lipid carrier-based hydrogel formulationChem Pharm Bull201462879379825087631
- SongCKBalakrishnanPShimCKChungSJChongSKimDDA novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluationColloids Surf B Biointerfaces20129229930422205066
- GeSLinYLuHPercutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interactionInt J Pharm201446512013124530389
- AggarwalNGoindiSDermatopharmacokinetic and pharmacodynamic evaluation of ethosomes of griseofulvin designed for dermal deliveryJ Nanoparticle Res201315101983
- AltuntasAYilmazHRAltuntasACaffeic Acid Phenethyl Ester Protects against Amphotericin B Induced Nephrotoxicity in Rat ModelBiomed Res Int2014201418
- GuptaMVyasSPDevelopment, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasisChem Phys Lipids2012165445446122309657
- ContiHRHupplerARWhibleyNGaffenSLAnimal models for candidiasisCurr Protoc Immunol2014105117
- AzeemATalegaonkarSNegiLMAhmadFJKharRKIqbalZOil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigationInt J Pharm20124221–243644422057087
- SahleFFMetzHWohlrabJNeubertRHHLecithin-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterizations, and in vitro release and penetration studiesPharm Res20133053855123135817
- NasseriAAboofazeliRZiaHNeedhamTLecithin stabilized microemulsion based organogels for topical application of ketorlac tromethamine. II. In vitro release studyIran J Pharm Res200322117123
- MalkinAIsayevAIRheology: Concepts, Methods & Applications2nd ed2012127221
- VicentiniFTMCCasagrandeRVerriWAGeorgettiSRBentleyMVLBFonsecaMJVQuercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stabilityAAPS PharmSciTech20089259159618454320
- ConeacGVlaiaVOlariuIDevelopment and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazoleAAPS PharmSciTech201516488990425591952
- OlariuIConeacGVlaiaLDevelopment and evaluation of microemulsion-based hydrogel formulations for topical delivery of propranolol hydrochlorideDig J Nanomater Biostructures201491395412
- LopesLBLopesJLCOliveiraDCRLiquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo deliveryEur J Pharm Biopharm200663214615516621488
- ShuklaJBPatelSJFormulation and evaluation of self micro emulsifying system of candesartan cilexetilInt J Pharm Pharm Sci20102425
- SerajuddinATMEnhanced microemulsion formation in lipid-based drug delivery systems by combining mono-esters of medium-chain fatty acids with di- or tri-estersJ Excipients Food Chem2012322944
- MoghimipourESalimiAKaramiMIsazadehSPreparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagramJundishapur J Nat Pharm Prod20138310511224624198
- MccarronPDonnellyRMaroufWCalvertDAnti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticlesInt J Pharm20073401–218219017482784
- BergssonGArnfinnssonJArnfinnssonHIn vitro killing of Candida albicans by fatty acids and monoglyceridesAntimicrob Agents Chemother200145113209321211600381
- ElnaggarYSREl-MassikMAAbdallahOYSildenafil citrate nanoemulsion vs self-nanoemulsifying delivery systems: rational development and transdermal permeationInt J Nanotechnol201188/9749763
- HiguchiTPhysical chemical analysis of percutaneous absorption process from creams and ointmentsJ Soc Cosmet Chem19601128597
- MoserKKriwetKNaikAKaliaYNGuyRHPassive skin penetration enhancement and its quantification in vitroEur J Pharm Biopharm200152210311211522474
- MadheswaranTBaskaranRYongCSYooBKEnhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactantsAAPS PharmSciTech2013151445124222268
- LuoMShenQChenJTransdermal delivery of paeonol using cubic gel and microemulsion gelInt J Nanomedicine201161603161021904450
- ValentaCWankaMHeidlasJEvaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drugJ Control Release2000631–216517310640590
- TanQLiuWGuoCZhaiGPreparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical deliveryInt J Nanomedicine201161621163021904452
- AzeemAAhmadFJKharRKTalegaonkarSNanocarrier for the transdermal delivery of an antiparkinsonian drugAAPS PharmSciTech20091041093110319757079
- LouHQiuNCrillCHelmsRAlmoazenHDevelopment of w/o microemulsion for transdermal delivery of iodide ionsAAPS PharmSciTech201314116817623250709
- StoyeISchroderKMuller-GoymannCCTransformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles – Physico-chemical characterization and influence on drug permeation through excised human stratum corneumEur J Pharm Biopharm19984621912009795056
- MakaiMCsányiENémethZPálinkásJErősIStructure and drug release of lamellar liquid crystals containing glycerolInt J Pharm20032561–29510712695015
- SwarbrickJSiverlyJRThe influence of liquid crystalline phases on drug percutaneous absorption. II. Permeation studies through excised human skinPharm Res1992912155015551488397
- El MaghrabyGMBarryBWWilliamsACLiposomes and skin: from drug delivery to model membranesEur J Pharm Sci2008344–520322218572392
- LvQYuAXiYDevelopment and evaluation of penciclovir-loaded solid lipid nanoparticles for topical deliveryInt J Pharm20093721–219119819429280